Skip to main content
. 2011 Oct 11;3(1):129–133. doi: 10.3892/etm.2011.363

Figure 3.

Figure 3.

Monitoring of MRD in AML patients by relative expression of the WT1 gene in PB. – •• – •• –, Median of WT1 expression in normal PB; – • – • –, median of WT1 expression in normal PB plus 3 SD in normal healthy donors; •••••••••••, upper remission limit of AML patients in permanent remission, relative level = 0.02.